The 20 Best Maturity Onset Diabetes of the Young Doctors Near Me in Baltimore, MD

Kashif Munir is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Munir is rated as a Distinguished provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Thyroid Cancer, Thyroid Storm, Pituitary Tumor, and Thyroidectomy.

Justin Tcheugui is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Tcheugui is rated as a Distinguished provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Gestational Diabetes, and Type 1 Diabetes (T1D). Dr. Tcheugui is board certified in American Board Of Internal Medicine.

Lina Melhem is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Melhem is rated as a Distinguished provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Juvenile Primary Osteoporosis, Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), and Hypothyroidism.

Rozalina Mccoy is an Endocrinologist practicing medicine in Baltimore, Maryland. She has been practicing medicine for over 17 years. Dr. Mccoy is rated as a Distinguished provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Diabetic Hyperglycemic Hyperosmolar Syndrome.

Paul Sack is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Sack is rated as a Distinguished provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), and Hypothyroidism.

Malek Cheikh is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Cheikh is rated as a Distinguished provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Osteoporosis, and Postmenopausal Osteoporosis.

Dr. Rita Kalyani is a Professor of Medicine at Johns Hopkins School of Medicine. She graduated with an undergraduate degree from Harvard College and completed her medical degree, residency, and fellowship at Johns Hopkins. She also obtained a Masters in Health Science degree in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. As a NIH-funded clinician scientist, Dr. Kalyani has authored over 175 peer-reviewed publications and built a research program focused on understanding the factors leading to development of diabetes complications, particularly in high-risk populations. She has conducted epidemiological and patient-oriented research that has led to fundamental discoveries regarding the development of skeletal muscle loss, physical disability, and frailty in diabetes. She has also spearheaded studies investigating sex differences in cardiovascular disease and diabetes which have influenced primary prevention guidelines. Dr. Kalyani launched the Diabetes Management Service for Johns Hopkins’ Total Pancreatectomy Islet Auto Transplant Program in 2011. She is the co-founder of the Johns Hopkins Diabetes POC-IT Guide for healthcare professionals. She is also the founder and past Editor-in-Chief of the Johns Hopkins Patient Website to Diabetes. Dr. Kalyani has been the Chief Scientific and Medical Officer of the American Diabetes Association since 2025. She previously served as President of Medicine & Science on the ADA's National Board of Directors. She continues to have a clinical practice as an adult endocrinologist. Dr. Kalyani is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Seasonal Affective Disorder (SAD), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Pancreatectomy, and Islet Cell Transplantation.

Dr. Donner's clinical and research interests have focused on the prevention of complications in patients with type 1 and 2 diabetes. For 6 years, he was the Associate Medical Director of the Joslin Diabetes Center affiliate at the University of Maryland, and then Medical Director from 2004 - 2010. After joining the faculty at Johns Hopkins University in 2010, his clinical and research interests became fully dedicated to diabetes. He became the Director of The Johns Hopkins Diabetes Center in 2011. He has been a clinical investigator in a number of NIH- and industry-funded diabetes research trials. Dr. Donner was a co-PI in the NIH-funded Veterans Affairs Implantable Insulin Pump Study, a Co-PI on the NIDDK-funded Diabetes Control and Complications Trial / Epidemiology of Diabetes Intervention and Complications (DCCT / EDIC) Study for 16 years, and Co-PI for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) for 7 years. Recently, he has served as PI for the Durable-response therapy Evaluation For Early or New-onset type 1 Diabetes (DEFEND-1). Dr. Donner is currently collaborating with Dr. Abdel Hamad in Immunology on preventing B-regulatory cell apoptosis using a novel monoclonal antibody targeting the presumptive apoptotic factor. This antibody prevents the development of type 1 diabetes in non obese diabetic mice. Dr. Donner is the PI for Johns Hopkins for TrialNet, a multicenter, international consortium of investigators studying ways to prevent Type 1 diabetes and preserve insulin secretion in individuals with newly diagnosed Type 1 diabetes. He is also a PI for a study investigating FIAsp, a faster-acting insulin aspart in subjects with type 1 diabetes, and is working with investigators at the Johns Hopkins School of Engineering on an implantable insulin pump which delivers insulin intravenously. Dr. Donner is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Diabetic Nephropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young. Dr. Donner is board certified in American Board Of Internal Medicine.

Todd T. Brown, MD, PhD is a clinical investigator who focuses on body composition, metabolic, and skeletal abnormalities observed in people with HIV, particularly as related to aging. Through translational investigation, epidemiologic studies, and clinical trials, he has been interested in understanding the pathogenesis of glucose disorders, fat changes, hormonal dysregulation, and osteoporosis in people with HIV, the consequences of these conditions (eg cardiovascular disease, frailty), and their optimal evaluation and management. Dr. Brown is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Low Blood Sugar, Osteoporosis, Malnutrition, Gastric Bypass, and Gastrostomy.

Dr. Mathioudakis, an endocrinologist and researcher, has a strong focus on diabetes management and patient care, recognized through awards like the Baltimore Top Doc. He has contributed significantly to diabetes research, authoring over 150 publications and participating in the development of consensus guidelines in the field. His studies have offered valuable insights into using health informatics for diabetes prevention and management. After graduating from the Johns Hopkins University School of Medicine and completing his training in Internal Medicine and a fellowship in Endocrinology, Diabetes, & Metabolism, Dr. Mathioudakis joined the faculty in the Division of Endocrinology, Diabetes & Metabolism in 2012. He earned a Master of Health Science in clinical investigation in 2015 and was the Clinical Director of the Division of Endocrinology from 2016 to 2021. Currently, he co-directs the Baltimore Metropolitan Diabetes Regional Partnership, focusing on improving access to diabetes prevention and management programs. As a physician-scientist, Dr. Mathioudakis leads multiple research studies funded by the NIH, private philanthropic organizations (Helmsley Charitable Trust), non-profit organizations (Breakthrough T1D), and industry. His research focuses on the effectiveness of automated diabetes prevention programs and strategies to reduce racial disparities in diabetes technology access. He also collaborates nationally to enhance care for people with type 1 diabetes. Holding a joint appointment in the Division of Biomedical Informatics and Data Science, Dr. Mathioudakis integrates machine learning and AI in diabetes research. He has served on the national Epic Endocrinology Specialty Steering Board and chaired the Type 2 Diabetes Prognostics Working Group for the Precision Medicine Diabetes Initiative. Committed to education, he frequently lectures on endocrinology, epidemiology, and health informatics. Dr. Mathioudakis is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Low Blood Sugar, Diabetic Ketoacidosis, and Pancreaticoduodenectomy.

Rexford Ahima is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Ahima is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Obesity, Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Sleeve Gastrectomy, and Gastric Bypass.

Colleen Leavitt, M.D., practices internal medicine and pediatrics at Johns Hopkins Community Physicians. She received her medical degree and completed her residency in medicine & pediatrics at Loyola University School of Medicine. Dr. Leavitt is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension. Dr. Leavitt is board certified in American Board Of Pediatrics and American Board Of Internal Medicine.

Dr. Sudipa Sarkar is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include endocrinology. She received her M.D. from Yale School of Medicine. She completed her residency in internal medicine at Yale-New Haven Hospital and performed a fellowship in endocrinology, diabetes and metabolism at Vanderbilt University Medical Center. Dr. Sarkar joined the Johns Hopkins faculty in 2017. Dr. Sarkar is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Diabetic Retinopathy, Maturity Onset Diabetes of the Young, Diabetic Neuropathy, and Sleeve Gastrectomy. Dr. Sarkar is board certified in American Board Of Internal Medicine.

Dr. Prasanna Santhanam received his M.B.B.S. from B.J. Medical College and his M.D. from N.H.L. Municipal Medical College. He completed a residency in internal medicine, Joan C Edwards School of Medicine, Marshall University and a fellowship in endocrinology, diabetes, and metabolism at Joan C Edwards School of Medicine, Marshall University. He underwent additional training in nuclear medicine, at the Department of Radiology and Radiological Sciences at Johns Hopkins University School of Medicine, to pursue his research and clinical interests in nuclear medicine and molecular imaging of endocrine glands and disorders. His clinical interests include thyroid disorders, endocrine neoplasms, and research focus on metabolic and molecular imaging of endocrine tissues and predictive analytics in metabolic disorders. Dr. Santhanam is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Papillary Thyroid Cancer, Anaplastic Thyroid Cancer, and Thyroidectomy.

Sherita Golden is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Golden is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Low Blood Sugar, and Hormone Replacement Therapy (HRT).

Dr. Stephen D. Sisson is a professor of medicine at the Johns Hopkins University School of Medicine. Dr. Sisson’s area of clinical expertise is internal medicine. He serves as vice president of clinical operations for the Office of Johns Hopkins Physicians, and as director of the Johns Hopkins Physician Education and Assessment Center (PEAC). He is the Philip A. Tumulty Professor of Medicine. Dr. Sisson holds a B.S. in chemistry from Duke University. He earned his M.D. (Alpha Omega Alpha, with research honors) at Tufts University School of Medicine. He completed an internal medicine internship and residency at Johns Hopkins, serving as assistant chief of service for the Barker Firm. He joined the Johns Hopkins faculty in 1996. He served for 15 years as the associate director of the Osler Medical Housestaff Training Program. His research interests include community outreach, medical education and ambulatory care. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Sisson is rated as an Experienced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. His clinical expertise encompasses COVID-19, Cerebral Palsy, Hypereosinophilic Syndrome, and Acute Eosinophilic Pneumonia. Dr. Sisson is board certified in American Board Of Internal Medicine.

Dr. Sara Mixter is Assistant Professor of Medicine and Pediatrics at the Johns Hopkins University School of Medicine. Her areas of clinical expertise are internal medicine, pediatrics, and primary care for adults with developmental disabilities and other complex childhood-onset conditions. She is the director of the Hopkins PACT (Pediatric-informed Adult Care and Transition) Clinic. Dr. Mixter is also the medical director of the Pediatric Complex Care Collaborative (PC3) for the Johns Hopkins Children’s Center. Dr. Mixter received her A.B. from Harvard College. She earned her M.D. from Harvard Medical School and M.P.H. from the Harvard School of Public Health. She completed her residency at Johns Hopkins as part of the inaugural group of trainees in the Urban Health Combined Internal Medicine-Pediatrics Residency Program. Her research interests include transitions of care for adolescents with special healthcare needs and education for residents and medical students, especially in primary care and complex care. Dr. Mixter has served as the Assistant Chief of Service for the Longcope firm of the Osler Medical Housestaff Training Program (2015-16), as well as Assistant Program Director for Ambulatory Education (2014-15). Dr. Mixter is rated as an Experienced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Cerebral Palsy, Gastroparesis, Orbital Cellulitis, and Sickle Cell Disease. Dr. Mixter is board certified in American Board Of Pediatrics and American Board Of Internal Medicine.

Dr. Dobs is presently an active clinical researcher in the field of endocrine gonadal function. She is particularly interested in new forms of male hormone replacement therapy and has published extensively in the area of hormonal changes with aging and chronic disease. Her clinical practice covers general endocrinology, with a focus on sex hormone disorders in both men and women. As Director of the Johns Hopkins Clinical Research Network, she oversees a multi-institutional consortium of hospitals in the mid-Atlantic states dedicated to facilitating clinical research through an academic-community hospital partnership. Dr. Dobs is rated as an Experienced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Hypogonadism, Testicular Failure, Eunuchoidism Familial Hypogonadotropic, Isolated Hypogonadotropic Hypogonadism, and Hormone Replacement Therapy (HRT). Dr. Dobs is board certified in American Board Of Internal Medicine.

Rachelle Smith, M.D., practices internal medicine and pediatrics at Johns Hopkins Community Physicians East Baltimore Medical Center. She received her medical degree from Duke University School of Medicine, and completed her residency in internal medicine and pediatrics at University of Rochester Medical Center. Videos Caring for the CommunityMeet Dr. Rachelle Smith. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. Her clinical expertise encompasses Maturity Onset Diabetes of the Young, Behcet Disease, Type 2 Diabetes (T2D), and Glucocorticoid-Remediable Aldosteronism. Dr. Smith is board certified in American Board Of Internal Medicine and American Board Of Pediatrics.

Dr. Venkataramani is an Assistant Professor of Medicine at the Johns Hopkins University School of Medicine. She is a general internist and general pediatrician with a clinical interest in primary care. Her research interests include improving the delivery of primary care and preventive services to underserved and low-income communities through family-oriented, community-based approaches and studying the impacts of health-related policies across generations. She received her M.D. from the Johns Hopkins University School of Medicine. She completed her residency at the Harvard Brigham and Women's/Boston Children's Hospital combined internal medicine/pediatrics residency program. She completed a research fellowship in General Internal Medicine at Johns Hopkins. She also earned an M.P.H. from the Johns Hopkins Bloomberg School of Health. Dr. Venkataramani is rated as an Experienced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. Her clinical expertise encompasses Type 2 Diabetes (T2D) and Maturity Onset Diabetes of the Young. Dr. Venkataramani is board certified in American Board Of Pediatrics and American Board Of Internal Medicine.